DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
72.53
-0.51 (-0.70%)
At close: Feb 2, 2026, 4:00 PM EST
72.65
+0.12 (0.17%)
Pre-market: Feb 3, 2026, 7:01 AM EST
DexCom Employees
DexCom had 10,300 employees as of December 31, 2024. The number of employees increased by 700 or 7.29% compared to the previous year.
Employees
10,300
Change (1Y)
700
Growth (1Y)
7.29%
Revenue / Employee
$438,437
Profits / Employee
$69,971
Market Cap
28.29B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 10,300 | 700 | 7.29% |
| Dec 31, 2023 | 9,600 | 2,000 | 26.32% |
| Dec 31, 2022 | 7,600 | 600 | 8.57% |
| Dec 31, 2021 | 7,000 | 600 | 9.38% |
| Dec 31, 2020 | 6,400 | 1,200 | 23.08% |
| Dec 31, 2019 | 5,200 | 1,300 | 33.33% |
| Dec 31, 2018 | 3,900 | 910 | 30.43% |
| Dec 31, 2017 | 2,990 | 690 | 30.00% |
| Dec 31, 2016 | 2,300 | 791 | 52.42% |
| Dec 31, 2015 | 1,509 | 448 | 42.22% |
| Dec 31, 2014 | 1,061 | 296 | 38.69% |
| Dec 31, 2013 | 765 | 67 | 9.60% |
| Dec 31, 2012 | 698 | 78 | 12.58% |
| Dec 31, 2011 | 620 | 100 | 19.23% |
| Dec 31, 2010 | 520 | 135 | 35.06% |
| Dec 31, 2009 | 385 | 81 | 26.64% |
| Dec 31, 2008 | 304 | 52 | 20.63% |
| Dec 31, 2007 | 252 | -8 | -3.08% |
| Dec 31, 2006 | 260 | 105 | 67.74% |
| Dec 31, 2005 | 155 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Koninklijke Philips | 67,823 |
| GE HealthCare Technologies | 53,000 |
| Smith & Nephew | 18,060 |
| STERIS | 17,787 |
| Zimmer Biomet Holdings | 17,000 |
| Edwards Lifesciences | 15,800 |
| Bio-Rad Laboratories | 7,700 |
| Bio-Rad Laboratories | 7,700 |
DXCM News
- 4 days ago - HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire
- 6 days ago - Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time. - Business Wire
- 18 days ago - Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 20 days ago - DexCom, Inc. (DXCM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 22 days ago - Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook - Business Wire
- 26 days ago - Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer - Business Wire
- 6 weeks ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit – DXCM - GlobeNewsWire
- 6 weeks ago - 4 Reasons Why DexCom Could Be A Good Buy For 2026 - Seeking Alpha